Table 2. Changes in the conformation of the binding site due to vildagliptin (a DPP4 inhibitor) binding.
PDB | Active site atoms (a,b,c,d) | ab | ac | ad | bc | bd | cd | |
---|---|---|---|---|---|---|---|---|
2OQIA
apo 3W2TA holo |
GLU205OE2,GLU206OE2,SER630OG,TYR662OH,
GLU205OE2,GLU206OE2,SER630OG,TYR662OH, |
D
PD D PD |
3.9
75.7 5.6 -74.4 |
7.9
-193.4 9.1 -307.9 |
4.0
-94.5 6.1 -159.8 |
10.1
-269.1 9.4 -233.5 |
3.5
-170.2 5.1 -85.5 |
7.3
98.9 5.6 148.1 |